A study evaluating the treatment selection and outcome when changing antipsychotic treatment in schizophrenic patients - ETOS
Study identifier:NIS-NGR-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A non-interventional, prospective, open-label Study for the evaluation of the selection and outcome of the antipsychotic treatment switch in outpatients with schizophrenia - ETOS study
Medical condition
schizophrenia
Phase
N/A
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
574
Study type
Observational
Age
N/A
Date
Study Start Date: 01 Oct 2009
Primary Completion Date: 01 Sept 2010
Study Completion Date: 01 Sept 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| Antipsychotic outpatients with schizophrenia Switched treatment of antipsychotic outpatients with schizophrenia | - |
Contacts
Investigators
Principal Investigator
Panagiotis Pontikis
Marketing Company Medical and Regulatory Affairs Director, AstraZeneca S.A. Greece
